Add to ORKGDevelopment of vaccines for effective control of foodborne pathogens and infection represents an important development in reducing public health risk. Advancements in the area of biotechnology have increased innovative potential and allow new technologies to be used as a promising control strategy for alternatives to antibiotics. We have been working to create a novel vaccine platform that incorporates a subunit/epitope sequence, common for all E. coli strains (broad spectrum), into an inactivated orally administered vaccine platform that protects against infection and disease by inducing mucosal immunity
Many pathogens invade the host at the intestinal surface. To protect against these enteropathogens, ...
The ICI 2013 Mucosal Vaccine Workshop presentations covered a wide range of topics, these mainly fel...
Infecções associadas a cepas da Escherichia coli enterohemorrágica (EHEC), podem causar manifestaçõe...
Although most infections begin at a mucosal surface and may be prevented by effective vaccine stimul...
Recent developments in the field of vaccination against gut-borne bacterial illness are reviewed, in...
International audienceAmong the many vaccine approaches developed in the recent past, mucosal vaccin...
In pig livestock, pathogenic E. coli can contain different combinations of virulence factors such as...
Salmonella enterica subspecies enterica includes several serovars infecting both humans and other an...
Salmonella enterica subspecies enterica includes several serovars infecting both humans and other an...
Many infectious agents enter the body using the oral route and are able to establish infections in o...
There is an urgent and unmet need to develop effective vaccines to reduce the global burden of infec...
Many pathogens invade the host at the intestinal surface. To protect against these enteropathogens, ...
Many pathogens invade the host at the intestinal surface. To protect against these enteropathogens, ...
Control of Salmonella sp. in swine production undergoes a systemic vision of the problem, and an int...
It is widely recognized that mucosal immunization is the most efficient route of delivery to offer p...
Many pathogens invade the host at the intestinal surface. To protect against these enteropathogens, ...
The ICI 2013 Mucosal Vaccine Workshop presentations covered a wide range of topics, these mainly fel...
Infecções associadas a cepas da Escherichia coli enterohemorrágica (EHEC), podem causar manifestaçõe...
Although most infections begin at a mucosal surface and may be prevented by effective vaccine stimul...
Recent developments in the field of vaccination against gut-borne bacterial illness are reviewed, in...
International audienceAmong the many vaccine approaches developed in the recent past, mucosal vaccin...
In pig livestock, pathogenic E. coli can contain different combinations of virulence factors such as...
Salmonella enterica subspecies enterica includes several serovars infecting both humans and other an...
Salmonella enterica subspecies enterica includes several serovars infecting both humans and other an...
Many infectious agents enter the body using the oral route and are able to establish infections in o...
There is an urgent and unmet need to develop effective vaccines to reduce the global burden of infec...
Many pathogens invade the host at the intestinal surface. To protect against these enteropathogens, ...
Many pathogens invade the host at the intestinal surface. To protect against these enteropathogens, ...
Control of Salmonella sp. in swine production undergoes a systemic vision of the problem, and an int...
It is widely recognized that mucosal immunization is the most efficient route of delivery to offer p...
Many pathogens invade the host at the intestinal surface. To protect against these enteropathogens, ...
The ICI 2013 Mucosal Vaccine Workshop presentations covered a wide range of topics, these mainly fel...
Infecções associadas a cepas da Escherichia coli enterohemorrágica (EHEC), podem causar manifestaçõe...